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Healthcare Law
Kathryn Dunnam Harden*
I. INTRODUCTION
This Article serves as a review of significant healthcare
developments in the United States Court of Appeals for the Eleventh
Circuit during this past Survey period. Specifically, this Article will
cover cases, legislation, and trends involving COVID-19, healthcare
fraud, and reproductive rights.
II. COVID-19 REGULATION AND LITIGATION
The COVID-19 pandemic has now stretched over two years and has
“overtaken the 1918 influenza pandemic as the deadliest disease in
American history.”1 The federal government, along with the individual
states, have sought to issue numerous regulations and legislation to
address the novel and deadly disease. COVID-19 has proved to be
politically polarizing, and the various efforts to address the disease
have been met with opposition. Recent regulatory efforts by the federal
government are detailed below.
Effective November 5, 2021, the Occupational Safety and Health
Administration (OSHA) issued an “emergency temporary standard
(ETS) to protect unvaccinated employees of large employers (100 or
more employees) from the risk of contracting COVID-19 by strongly
encouraging vaccination.”2 The rule required that “[c]overed employers
must develop, implement, and enforce a mandatory COVID-19
vaccination policy, with an exception for employers that instead adopt a
policy requiring employees to either get vaccinated or elect to undergo

*Attorney, Hall Booth Smith, P.C. Mercer University (B.A., 2013); Mercer University
School of Law (J.D., 2016). Member, Mercer Law Review (2014–2016); Administrative
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1. Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff
Vaccination, 86 Fed. Reg. 61,555 (Nov. 5, 2021).
2. COVID-19 Vaccination and Testing; Emergency Temporary Standard, 86 Fed.
Reg. 61,402 (Nov. 5, 2021).
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regular COVID-19 testing and wear a face covering at work in lieu of
vaccination.”3
In response, “[s]cores of parties—including States, businesses, trade
groups, and nonprofit organizations—filed petitions for review, with at
least one petition arriving in each regional Court of Appeals. The cases
were consolidated in the Sixth Circuit, which was selected at random
pursuant to 28 U.S.C. § 2112(a).”4 In a per curiam opinion, the Supreme
Court of the United States ultimately granted the applications seeking
a stay of OSHA’s COVID-19 Vaccination and Testing ETS.5 The Court
held that “[a]pplicants are likely to succeed on the merits of their claim
that the Secretary lacked authority to impose the mandate,” because
the Occupational Safety and Health Act (The Act) does not plainly
authorize the Secretary’s mandate.6 In its reasoning, the Court
emphasized that the Act “empowers the Secretary to set workplace
safety standards, not broad public health measures.”7 The Court
contemplated that a permissible exercise of authority would be to
“regulate occupation-specific risks related to COVID-19,” such as
COVID-19 researchers or “risks associated with working in particularly
crowded or cramped environments.”8 To require large employers,
however, to implement mandatory vaccine measures was too broad an
exercise of power.9
Although Congress has indisputably given OSHA the power to
regulate occupational dangers, it has not given that agency the power
to regulate public health more broadly. Requiring the vaccination of
84 million Americans, selected simply because they work for
employers with more than 100 employees, certainly falls in the latter
category.10

Effective January 26, 2022, OSHA withdrew its November 2021
ETS.11 Thus, employers outside of the healthcare context are not
required to implement mandatory vaccine policies.

3. Id.
4. Nat’l Fed’n of Indep. Bus. v. Dep’t of Lab., Occupational Safety and Health
Admin., 142 S. Ct. 661, 664 (2022).
5. Id. at 666–67.
6. Id. at 664–65.
7. Id. at 665 (emphasis in original).
8. Id. at 665–66.
9. Id. at 666.
10. Id.
11. COVID-19 Vaccination and Testing; Emergency Temporary Standard, 87 Fed.
Reg. 3928 (Jan. 26, 2022).
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Other regulatory efforts have fared better. Effective November 5,
2021, the Secretary of Health and Human Services and Centers for
Medicare and Medicaid Services issued a rule requiring that the nonexempt staff of healthcare facilities be vaccinated against COVID-19 in
order to receive funding.12 The vaccine mandate was sought in order “to
help protect the health and safety of residents, clients, patients, PACE
participants, and staff, and reflect lessons learned to date as a result of
the COVID-19 public health emergency.”13 Indeed, “[a]s of mid-October
2021, over 44 million COVID-19 cases, 3 million new COVID-19 related
hospitalizations, and 720,000 COVID-19 deaths have been reported in
the U.S.”14
Multiple states, including two Eleventh Circuit states, Alabama and
Georgia, signed onto Louisiana’s Motion for Preliminary Injunction in
order to enjoin the new vaccine mandate from taking effect.15 The
United States District Court for the Western District of Louisiana
granted the injunctive relief.16 A second United States district court, the
United States District Court for the Eastern District of Missouri,
likewise granted an injunction against the new vaccine mandate as
sought by several different states.17 In both cases, the federal
government then sought a stay of the injunctions in each respective
United States court of appeals.18 The stays were denied by both the
United States Court of Appeals for the Fifth Circuit and the United
States Court of Appeals for the Eighth Circuit.19
The federal government then filed applications to stay those
injunctions with the Supreme Court of the United States.20 In a per
curiam opinion, the Court ultimately granted the stays on January 13,
2022.21 The Court held that the “Secretary’s rule falls within the

12. Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff
Vaccination, 86 Fed. Reg. 61,555 (Nov. 5, 2021).
13. Id.
14. Id. at 61,556.
15. Louisiana v. Becerra, No. 3:21-CV-03970, 2021 U.S. Dist. LEXIS 229949, at *1
(W.D. La. Nov. 30, 2021) (hereinafter Becerra I).
16. Id. at *2–3.
17. Missouri v. Biden, No. 4:21-cv-01329, 2021 U.S. Dist. LEXIS 227410, at *4 (E.D.
Mo. Nov. 29, 2021) (hereinafter Biden I).
18. Louisiana v. Becerra, 20 F.4th 260, 262 (5th Cir. 2021) (hereinafter Becerra II);
Order at 1, Missouri v. Biden, No. 21-3725 (8th Cir. 2021) (hereinafter Biden II).
19. Id.
20. Biden v. Missouri, 142 S. Ct. 647 (2022) (hereinafter Biden III).
21. Id. at 650.
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authorities that Congress has conferred upon him.”22 The Court
reasoned:
After all, ensuring that providers take steps to avoid transmitting a
dangerous virus to their patients is consistent with the fundamental
principle of the medical profession: first, do no harm. It would be the
“very opposite of efficient and effective administration for a facility
that is supposed to make people well to make them sick with COVID19.”23

In citing to the amici curiae briefs filed in the subject case, the Court
further noted that “healthcare workers and public-health organizations
overwhelmingly support the Secretary’s rule.”24 “We accordingly
conclude that the Secretary did not exceed his statutory authority in
requiring that, in order to remain eligible for Medicare and Medicaid
dollars, the facilities covered by the interim rule must ensure that their
employees be vaccinated against COVID-19.”25 The Court disagreed
with the States’ remaining arguments, including the argument that the
vaccine mandate was arbitrary and capricious.26
Consistent with the Supreme Court, in December 2021, the United
States Court of Appeals for the Eleventh Circuit upheld a district
court’s denial of Florida’s request for an injunction barring enforcement
of the vaccine mandate for healthcare staff.27 In sum, in order to receive
funding from Centers for Medicare and Medicaid Services, non-exempt
healthcare staff must be vaccinated.
III. FALSE CLAIMS ACT UPDATE
This Survey period produced another significant development in the
realm of Healthcare Fraud: Yates v. Pinellas Hematology & Oncology,
P.A.28 The United States Court of Appeals for the Eleventh Circuit held
that the Excessive Fines Clause of the Eighth Amendment does apply to
non-intervened qui tam actions brought under the False Claims Act
(FCA), a question previously left open by the Supreme Court of the
United States.29
22. Id. at 652.
23. Id. (quoting Florida v. Dep’t of Health and Hum. Servs., 19 F.4th 1271, 1288 (11th
Cir. 2021)).
24. Id. at 653.
25. Id.
26. Id. at 653–54.
27. Florida v. Dep’t of Health and Hum. Servs., 19 F.4th at 1275.
28. 21 F.4th 1288 (11th Cir. 2021).
29. Id. at 1307.
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Yates constituted a qui tam action filed by relator, Ms. Michele
Yates.30 The United States chose not to intervene in the action.31 In qui
tam actions where the United States does not intervene, the relator
brings the suit “‘in the name of the United States.’”32 In these cases, the
United States “generally receives between 70 and 75 percent of the
recovery, with the relator receiving the rest.”33 The Eleventh Circuit
described these cases as “fall[ing] in a grey area between disputes
amongst purely private parties and disputes pitting the United States
against a private party.”34
The Excessive Fines Clause of the Eighth Amendment applies to
fines imposed by the United States.35 The Eleventh Circuit rejected Ms.
Yates’s argument “that the monetary award here was not imposed by
the United States because it was not a party to the proceedings
below.”36 The False Claims Act “is a federal enactment, and therefore it
must comply with the Constitution.”37 The monetary awards under the
False Claims Act constitute fines within the context of the Eighth
Amendment.38 Ultimately, the Eleventh Circuit reasoned that, given
the United States’ authority and power over a non-intervened qui tam
action, the monetary award is still imposed by the United States
despite it lacking formal party status.39 The FCA relator is considered a
government actor to trigger the Eighth Amendment, and the Excessive
Fines Clause does indeed apply to non-intervened qui tam actions
under the False Claims Act.40
The court further held that the monetary award imposed did not
violate the Excessive Fines Clause.41 To violate said clause, the fine
must be “‘grossly disproportional to the gravity of a defendant’s
offense.’”42 The Eleventh Circuit acknowledged that “a judgment of
$1.179 million based on $755.54 in actual damages may raise an
eyebrow,” but that the “optics . . . are negated when one realizes that
this total is the result of Pinellas’ repeated (214) instances of fraud
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.

Id. at 1295.
Id. at 1296.
Id. at 1307 (quoting 31 U.S.C. § 3730(b)(1) (2010)).
Id.
Id.
Id.
Id. at 1308–09.
Id. at 1309.
Id.
Id. at 1312–13.
Id. at 1309–10.
Id. at 1316.
Id. at 1314 (quoting U.S. v. Bajakajian, 524 U.S. 321, 334 (1988)).
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against the United States.”43 Moreover, “[t]he district court here
imposed the lowest-possible statutory penalty of $5,500 for all of the
214 violations, and treble damages are mandated by the FCA.”44 Thus,
the award was the lowest possible sanction available under the False
Claims Act and did not violate the Excessive Fines Clause.45
While the Eleventh Circuit’s holding that the Eighth Amendment’s
prohibition on Excessive Fines applies to non-intervened qui tam
actions brought under the False Claims Act is a favorable new
development for defendants, it remains to be seen what monetary
amount will constitute such an Excessive Fine in this context.
IV. REPRODUCTIVE RIGHTS
The reproductive health and rights of women continue to be matters
of contention and public debate in the current political climate.
In 2019, as initially reported in Healthcare Law,46 the Trump
Administration made drastic changes to the Title X programs so that
“none of the funds appropriated for Title X may be used in programs
where abortion is a method of family planning.”47 The 2019 rule also
eliminated the requirement for nondirective abortion counseling and
referral and prohibited referral for abortion.48 Notably, “Title X is the
only federal grant program dedicated solely to providing individuals
with comprehensive family planning and related preventive health
services.”49 A 2019 poll conducted by the Kaiser Family Foundation
showed that “[m]ost of the public (58%) oppose[d] changing the program
to exclude organizations that provide abortions or referrals for
abortions with other resources, while nearly four in 10 (38%) favor[ed]
such changes.”50
43. Id.
44. Id.
45. Id.
46. Kathryn Dunnam Harden, Healthcare Law, Eleventh Circuit Survey, 70 MERCER
L. REV. 1053 (2019).
47. Compliance With Statutory Program Integrity Requirements, 84 Fed. Reg. 7714
(Mar. 4, 2019).
48. Id.
49. About Title X Grants, HHS.GOV, https://www.hhs.gov/opa/title-x-familyplanning/about-title-x-grants/index.html (last visited Mar. 9, 2022).
50. Rakesh Singh & Craig Palosky, Poll Finds Most Americans Oppose the Trump
Administration’s Changes to Restrict Title X Family Planning Funds from Clinics that
also
Provide
or
Refer
for
Abortion,
KAISER
FAMILY
FOUNDATION,
https://www.kff.org/womens-health-policy/press-release/poll-finds-most-americans-opposetrump-administrations-changes-to-restrict-title-x-family-planning-funds-from-clinicsthat-provide-or-refer-for-abortion/ (last visited Mar. 10, 2022).
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In its Title X Family Planning Annual Report, the U.S. Department
of Health and Human Services (HHS) Office of Population Affairs
(OPA) detailed the effects of both the COVID-19 pandemic and the
Trump Administration’s regulatory changes on the number of clients
served.51 In the two-year period from 2018 to 2020, the number of
clients served decreased from 3.9 million to 1.5 million.52 The OPA
calculated that the 2019 rule accounted for 63% of the decrease in the
number of family planning clients served while the COVID-19
pandemic accounted for 37% of the decrease.53 The OPA further
reported that the 2019 rule “may have led to an estimated 181,477
unintended pregnancies.”54
In a triumph for reproductive health advocates, the Biden
Administration reinstated many provisions of the Title X programs that
were eliminated by the Trump Administration.
The effect of this 2021 final rule is to revoke the requirements of the
2019 regulations, including removing restrictions on nondirective
options counseling and referrals for abortion services and eliminating
requirements for strict physical and financial separation between
abortion-related activities and Title X project activities, thereby
reversing the negative public health consequences of the 2019
regulations.55

The 2021 rule is not without opposition. On October 25, 2021, the
States of Ohio, Alabama, Arizona, Arkansas, Florida, Kansas,
Kentucky, Missouri, Nebraska, Oklahoma, South Carolina, and West
Virginia moved jointly for a preliminary injunction against the Quality
Family Planning Rule.56 These states claimed the Biden
Administration’s changes to Title X violate Section 1008 of the Public
Health Service Act, which provides that the funds appropriated under
Title X cannot be used in programs where abortion is a method of
family planning.57 They further contended that the Trump
Administration’s 2019 changes to Title X complied with section 1008
51. OFFICE OF POPULATION AFFAIRS, TITLE X FAMILY PLANNING ANNUAL REPORT:
2020 NATIONAL SUMMARY (2021), https://opa.hhs.gov/sites/default/files/2021-09/title-xfpar-2020-national-summary-sep-2021.pdf.
52. Id. at ES-4.
53. Id. at ES-5–6.
54. Id. at ES-5.
55. Ensuring Access to Equitable, Affordable, Client-Centered, Quality Family
Planning Services, 86 Fed. Reg. 56144, 56144 (Nov. 8, 2021) (codified at 42 C.F.R. pt. 59).
56. Combined Mot. for a Prelim. Inj. and Mem. in Supp. of the Mot., Ohio v. Becerra,
No. 1:21-cv-675, 2021 U.S. DIST. LEXIS 247120 (S.D. Ohio Dec. 29, 2021).
57. Id. at 2–3, 4.
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because the 2019 rule (1) required Title X grantees to have financial
and physical separation from abortion referral services; and (2) “forbade
Title X grantees from making abortion referrals” within the Title X
program.58
On December 29, 2021, the United States District Court for the
Southern District of Ohio denied the States’ motion for injunctive
relief.59 On appeal from the district court’s denial, the United States
Court of Appeals for the Sixth Circuit likewise denied the States’
motion.60 The Sixth Circuit held that the States failed to show
irreparable harm from the 2021 rule and, thus, failed to meet the
burden for an injunction pending appeal.61 The Sixth Circuit expressed
no opinion on the merits of the States’ claims.62 Therefore, the 2021 rule
remains intact for now.
It remains to be seen whether or not the 2021 rule and its funding
will effectively reverse the damage from the 2019 rule, but the Biden
Administration is making steps in the right direction to prioritize the
reproductive health and rights of women.
V. CONCLUSION
This past Survey period has seen important updates in the field of
healthcare law. In the context of COVID-19, non-exempt healthcare
staff must be vaccinated in order to receive federal funding. In addition,
in a matter of first impression, the Eleventh Circuit held that the
Excessive Fines Clause of the Eighth Amendment does apply to nonintervened qui tam actions brought under the False Claims Act.
Finally, the Biden Administration rolled back the Trump
Administration’s Title X restrictions, in a triumph for the champions of
women’s reproductive health and rights.

58. Id. at 7–8.
59. Ohio v. Becerra, No. 1:21-cv-675, 2021 U.S. Dist. LEXIS 247120, at *15 (S.D. Ohio
Dec. 29, 2021).
60. Ohio v. Becerra, No. 21-4235, 2022 U.S. App. LEXIS 3435, at *21 (6th Cir. Feb. 8,
2022).
61. Id. at *20–21.
62. Id. at *20.

